Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 3
1998 2
1999 3
2000 3
2001 7
2002 1
2003 2
2005 3
2006 1
2007 4
2008 2
2009 4
2010 5
2011 2
2012 6
2013 6
2014 6
2015 7
2016 8
2017 5
2018 8
2019 11
2020 6
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 24942514

98 results

Results by year

Filters applied: . Clear all
Page 1
Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
Namikoshi T, Harada K, Hatta H, Tokura T, Oshiro Y, Nishizaki T, Obata T, Mori M, Fueki T, Fujimoto S, Haruna Y, Kuwabara A, Yorimitsu D, Ihoriya C, Kadoya H, Itano S, Fujimoto Y, Komai N, Sasaki T, Kashihara N. Namikoshi T, et al. Clin Exp Nephrol. 2016 Feb;20(1):134-42. doi: 10.1007/s10157-015-1130-2. Epub 2015 May 31. Clin Exp Nephrol. 2016. PMID: 26026991
Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial.
Foocharoen C, Chunlertrith K, Mairiang P, Mahakkanukrauh A, Suwannaroj S, Namvijit S, Wantha O, Nanagara R. Foocharoen C, et al. Rheumatology (Oxford). 2017 Feb;56(2):214-222. doi: 10.1093/rheumatology/kew216. Epub 2016 May 13. Rheumatology (Oxford). 2017. PMID: 27179107 Clinical Trial.
Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial.
Sirinawasatien A, Kantathavorn N. Sirinawasatien A, et al. Clin Exp Gastroenterol. 2019 Jul 26;12:337-347. doi: 10.2147/CEG.S214677. eCollection 2019. Clin Exp Gastroenterol. 2019. PMID: 31440072 Free PMC article.
98 results